EP0527783A4 - Method of treatment with hsp70 - Google Patents

Method of treatment with hsp70

Info

Publication number
EP0527783A4
EP0527783A4 EP19910908050 EP91908050A EP0527783A4 EP 0527783 A4 EP0527783 A4 EP 0527783A4 EP 19910908050 EP19910908050 EP 19910908050 EP 91908050 A EP91908050 A EP 91908050A EP 0527783 A4 EP0527783 A4 EP 0527783A4
Authority
EP
European Patent Office
Prior art keywords
hsp70
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910908050
Other versions
EP0527783A1 (en
Inventor
Paul A. C/O Sandoz Pharmaceuticals Berberian
Michael Tytell
David J. Post Office Box 26307 Gower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University
Original Assignee
Wake Forest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University filed Critical Wake Forest University
Publication of EP0527783A1 publication Critical patent/EP0527783A1/en
Publication of EP0527783A4 publication Critical patent/EP0527783A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19910908050 1990-04-06 1991-04-05 Method of treatment with hsp70 Withdrawn EP0527783A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50593490A 1990-04-06 1990-04-06
US505934 1990-04-06

Publications (2)

Publication Number Publication Date
EP0527783A1 EP0527783A1 (en) 1993-02-24
EP0527783A4 true EP0527783A4 (en) 1993-09-01

Family

ID=24012485

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910908050 Withdrawn EP0527783A4 (en) 1990-04-06 1991-04-05 Method of treatment with hsp70

Country Status (5)

Country Link
EP (1) EP0527783A4 (en)
JP (1) JPH05507908A (en)
AU (1) AU659085B2 (en)
CA (1) CA2079813A1 (en)
WO (1) WO1991015219A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5847007A (en) * 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
ES2246566T5 (en) 1998-03-27 2010-10-26 Gabriele Prof. Dr. Multhoff APPLICATION OF HSP70 PROTEINS.
US6812205B2 (en) * 2000-03-15 2004-11-02 The Brigham & Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
CA2458574A1 (en) 2001-08-23 2003-03-06 Arizona Board Of Regents Reagents and methods for smooth muscle therapies
DE60335549D1 (en) * 2003-11-12 2011-02-10 Alfa Biogene Internat B V Recovery of heat shock proteins
CN101801402B (en) 2007-07-06 2013-08-28 乌得勒支大学控股有限公司 Treatment and prevention of inflammatory diseases and autoimmune diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9115219A1 *
SUPPLEMENT TO INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE vol. 28, no. 3, March 1987, page 141 M.F. BARBE ET AL. 'Heat shock proteins may enhance retinal survival following light damage' *

Also Published As

Publication number Publication date
WO1991015219A1 (en) 1991-10-17
AU659085B2 (en) 1995-05-11
JPH05507908A (en) 1993-11-11
CA2079813A1 (en) 1991-10-07
EP0527783A1 (en) 1993-02-24
AU7677391A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
GB9027968D0 (en) Method of treatment
EP0527783A4 (en) Method of treatment with hsp70
GB9202196D0 (en) Method of treatment
GB9201391D0 (en) Method of treatment
PL286564A1 (en) Method of treatment of extragrade pantaerythrite
GB9014959D0 (en) Method of treatment
GB9001029D0 (en) Method of treatment
GB9016831D0 (en) Method of treatment
GB9026564D0 (en) Method of treatment
GB9001031D0 (en) Method of treatment
GB9001028D0 (en) Method of treatment
RU1833739C (en) Way of treatment hyperekaliemia
GB9101000D0 (en) Method of treatment
GB9101001D0 (en) Method of treatment
GB9101175D0 (en) Method of treatment
GB9105617D0 (en) Method of treatment
GB9104267D0 (en) Method of treatment
GB9101176D0 (en) Method of treatment
CS275125B2 (en) Method of magnesite treatment and equipment for its realization
GB9124842D0 (en) Novel method of treatment
GB9202020D0 (en) Method of treatment
GB9202698D0 (en) Method of treatment
GB9207275D0 (en) Method of treatment
GB9218188D0 (en) Method of treatment
GB9223252D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19921008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BERBERIAN, PAUL, A.,C/O SANDOZ PHARMACEUTICALS

Inventor name: GOWER, DAVID, J. POST OFFICE BOX 26307

Inventor name: TYTELL, MICHAEL

A4 Supplementary search report drawn up and despatched

Effective date: 19930715

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19960108

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980519